Sagimet Biosciences gives going public a second chance under new CEO By: MarketWatch June 23, 2023 at 19:52 PM EDT Biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filing with the SEC late Friday. Read More >> Related Stocks: Renaissance IPO ETF
